Kuaile L. Zhao
No. 3 Yingrui Road
Jiangyin, China
Jiangyin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications
Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial.
Journal: Future oncology (London, England)
Published: March 04, 2026
Nrf2 deficiency converts the ESCC microenvironment into an immunologically active state via the GPX2-ICD-DC signaling path.
Journal: Journal of translational medicine
Published: January 22, 2026
The AGPS regulatory variant rs113671272 confers esophageal squamous cell carcinoma susceptibility through allele-specific MEIS3 binding and NF-κB activation in Chinese populations.
Journal: EBioMedicine
Published: September 21, 2025
Validation and refinement of the 8th edition of the AJCC staging system for esophageal squamous cell carcinoma treated with definitive IMRT or chemo-IMRT: a Chinese multi-institutional retrospective study.
Journal: Radiation oncology (London, England)
Published: August 28, 2025
Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trials.
Journal: Clinical and translational radiation oncology
Published: August 17, 2025
The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort study.
Journal: Therapeutic advances in medical oncology
Published: August 06, 2025
ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCC.
Journal: Future oncology (London, England)
Published: July 30, 2025
Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching study.
Journal: Cancer immunology, immunotherapy : CII
Published: June 19, 2025
Pattern of Lymph Node Metastases and Recurrence in Thoracic Small Cell Esophageal Carcinoma: A Single-Institution Experience.
Journal: Annals of surgical oncology
Published: May 23, 2025
PD-1 inhibitor improves radiosensitivity by tumor vessel normalization.
Journal: British journal of cancer
Published: May 05, 2025
Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinoma.
Journal: Signal transduction and targeted therapy
Published: January 23, 2025
Last Updated: 09/26/2026